Sodium Chloride Injection, USP in VIAFLEX Plastic Container DESCRIPTION Sodium Chloride Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers for intravenous administration. It contains no antimicrobial agents. The nominal pH is 5.0 (4.5 to 7.0).Composition, Baxter 0.9% Sodium Chloride Injection USP - 1000ml - (Baxter 百特醫療)10336. Baxter 0.
Dec 24, 2018 · Sodium Chloride 0.9% intravenous infusion is an isotonic solution, with an approximate osmolarity of 308 mOsm/l. The pharmacodynamic properties of the solution are those of the sodium and chloride ions in maintaining the fluid and electrolyte balance. Sodium Chloride 0.9% Injection will be given to you by your doctor or specially trained nurse by infusion or drip into the vein or applied to open The dosage you will be given will depend on your age, weight, medical condition and response. Your doctor will have experience in injecting Sodium...We are offering sodium chloride .0.9 injection ip 30ml. Small volume parenteral that we sell is manufactured under proper hygienic condition. Our small volume parenterals is well packed to avoid any leakage and is sterile.Sodium Chloride Injection, USP is an intravenously administered injectable indicated as a source of water and electrolytes and for use as a priming solution in hemodialysis procedures. These 50 mL and 100 mL containers are primarily used for admixture of medication and as priming solutions.
Dec 24, 2018 · Sodium Chloride 0.9% intravenous infusion is an isotonic solution, with an approximate osmolarity of 308 mOsm/l. The pharmacodynamic properties of the solution are those of the sodium and chloride ions in maintaining the fluid and electrolyte balance. Plasma-lyte A with NDC 0338-0221 is a a human prescription drug product labeled by Baxter Healthcare Corporation. The generic name of Plasma-lyte A is sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride. The product's dosage form is injection, solution and is administered via intravenous form.
Aug 05, 2017 · The recall affects one lot of 0.9 percent sodium chloride, USP 1000mL, which was manufactured in the U.S. by Hospira, a Pfizer company, on Feb. 1, 2016, and distributed nationwide to Hospira customers between April 14, 2016, and Feb. 2, 2016. The affected product is marked with the NDC 0409-7983-09, Lot # 61-841-FW and expires Jan. 1, 2018. 2.1 Important Administration Instructions • Dextrose and Sodium Chloride Injection is only for intravenous infusion. • The osmolarity of Dextrose and Sodium Chloride Injection, ranges from 280 to 560 mOsmol/L (calc). Peripheral administration is generally acceptable; however; consider central vein administration if there is peripheral